Furthermore, they also exhibit immunosuppressive properties upon transplantation.3 It has already been described that MSC positively influence angiogenesis of blood vessels and the revascularization of ischemic tissue through the secretion of blood endothelial cell (BEC) stimulating factors.4 MSC also contribute to the formation of tumour blood vessels via integration as atypical vascular endothelial growth factor A (VEGF‐A) secreting cells.5 In contrast to the well‐characterized relationship between BEC and MSC, however, little is known about lymphatic endothelial cell (LEC)‐MSC interaction. The gene discussed is VEGFA; the disease is neoplasm.